Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits

収録刊行物

被引用文献 (7)*注記

もっと見る

問題の指摘

ページトップへ